Abstract
Antibody-drug conjugates (ADCs) represent an exciting and promising therapeutic approach for the treatment of cancers. The US Food and Drug Administration’s recent approval of brentuximab vedotin (...
Cite
CITATION STYLE
APA
Beck, A. (2014). Review of Antibody-Drug Conjugates, Methods in Molecular Biology series. MAbs, 6(1), 30–33. https://doi.org/10.4161/mabs.27005
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free